Source: Marketing Authorisation Holder Revision Year: 2022 Publisher: Novagen Pharma (Pty) Ltd., Office 2, 100 Sovereign Drive, Route 21 Corporate Park, Nellmapius Drive, Irene-Pretoria, South Africa, (t) +27 12 345 3175
DENSATE 70 mg (Tablet) - Sodium alendronate.
Pharmaceutical Form |
---|
DENSATE 70 mg: White to off-white, oval shaped, biconvex, uncoated tablets, debossed with ‘F’ on one side and ‘21’ on the other side. |
The active substance is sodium alendronate.
DENSATE 70 mg: Each uncoated tablet contains sodium alendronate equivalent to alendronic acid 70 mg.
Sugar free.
Active Ingredient | Description | |
---|---|---|
Alendronic acid |
Alendronic acid is a bisphosphonate that inhibits osteoclastic bone resorption with no direct effect on bone formation. The bone formed during treatment with alendronic acid is of normal quality. |
List of Excipients |
---|
The other ingredients are cellulose microcrystalline, magnesium stearate, maize starch, povidone and sodium starch glycolate. |
DENSATE 70 mg: Tablets are packed in printed aluminium foil with heat seal lacquer and clear PVC laminated with aclar.
Each blister contains 4 tablets.
Pack size: 4’s – Each carton contains 1 blister of 4 tablets each.
Novagen Pharma (Pty) Ltd., Office 2, 100 Sovereign Drive, Route 21 Corporate Park, Nellmapius Drive, Irene-Pretoria, South Africa, (t) +27 12 345 3175
DENSATE 70 mg: 45/3.2/0581
Date of registration: 01 March 2013
Date of notification with regard to amended Reg. 9 and 10: 02 February 2015
Drug | Countries | |
---|---|---|
DENSATE | Australia, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.